Kinesiophobia in Postmenopausal Osteoporosis
Kinesiophobia and Associated Factors in Postmenopausal Osteoporosis: A Controlled Study
1 other identifier
observational
60
1 country
1
Brief Summary
This study aims to evaluate kinesiophobia levels in postmenopausal women with osteoporosis compared to a healthy control group and to explore the relationships between kinesiophobia and various psychosocial factors, including quality of life, fear of falling, and symptoms of depression and anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2024
CompletedFirst Submitted
Initial submission to the registry
July 20, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedJuly 25, 2024
July 1, 2024
1 month
July 20, 2024
July 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tampa Scale for Kinesiophobia (TSK)
The Tampa Scale for Kinesiophobia (TSK) is a widely used tool for assessing fear of movement and physical activity, often referred to as kinesiophobia.
0 day
Secondary Outcomes (3)
Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41)
0 day
Hospital Anxiety and Depression Scale (HADS)
0 day
Tinetti Falls Efficacy Scale (TFES)
0 day
Study Arms (2)
Postmenopausal osteoporosis
Postmenopausal osteoporosis
Control group
Healthy group
Interventions
Eligibility Criteria
Osteoporosis Group: This group included 60 postmenopausal women diagnosed with osteoporosis. Participants were required to have been under follow-up for at least six months. Control Group: This group comprised 60 healthy postmenopausal women who were neither osteoporotic nor osteopenic
You may qualify if:
- Diagnosis: Participants must be diagnosed with postmenopausal osteoporosis and have been under follow-up for at least six months.
- Age: Individuals must be 50 years or older.
- Health Status: Participants must have excluded secondary causes of osteoporosis.
You may not qualify if:
- Comorbid Conditions: Presence of other musculoskeletal, neurological, or psychiatric diseases that could influence kinesiophobia or pain.
- Cognitive or Communication Difficulties: Any cognitive dysfunction or communication issues that might impair the participant's ability to engage with the study.
- Acute Conditions: Presence of acute painful conditions that might affect the results.
- Medications: Use of medications or presence of diseases that could cause balance or functional disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beylikdüzü State Hospital
Istanbul, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
July 20, 2024
First Posted
July 25, 2024
Study Start
January 21, 2024
Primary Completion
February 21, 2024
Study Completion
February 21, 2024
Last Updated
July 25, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share